Corium acquires StrataGent, raises $25.1M for “transdermal” drugs
See our story about these companies in Menlo Park, Calif., and San Jose, Calif., in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Osprey Pharma names new CEO
Previous Story: PPLive, Chinese P2P video site, raises $21M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.